Abstract
Artificial magnetotactic probiotics (AMPs) are developed to combine living probiotic benefits with magnetic targeting properties. Experimental investigations are carried out to study their surface nano-modification process, viability and magnetic motility behavior. Subsequent in vivo studies indicate that AMPs can be applied to inhibit different invasive pathogens, including some antibiotic-resistant strains. Compared with conventional antibiotic therapy, AMPs represent an efficient and accurate alternative treatment for dealing with microbial threats, and have the potential to minimize a wide range of adverse effects.